Activest Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$87.5K Buy
1,403
+14
+1% +$885 0.02% 196
2026
Q2
$80K Sell
1,389
-767
-36% -$44K 0.02% 209
2026
Q1
$131K Buy
2,156
+536
+33% +$31.2K 0.02% 197
2025
Q4
$87.4K Buy
1,620
+1,090
+206% +$52.4K 0.02% 235
2025
Q3
$23.9K Buy
530
+163
+44% +$7.61K ﹤0.01% 356
2025
Q2
$17K Buy
367
+163
+80% +$8K ﹤0.01% 350
2025
Q1
$12.4K Buy
204
+192
+1,600% +$11.2K ﹤0.01% 361
2024
Q4
$679 Buy
+12
New +$670 ﹤0.01% 498

Other funds holding BMY

Activest Wealth Management's BMY Position: Q3 2026 in Review

Activest Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 1% in Q3 2026, buying an estimated $885 and bringing the position to 1,403 shares worth $87.5K. The position accounts for 0.02% of the portfolio, ranked #196.

Activest Wealth Management first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. The position peaked at $131K in Q1 2026. 1,000 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Activest Wealth Management held 1,403 shares of Bristol-Myers Squibb worth $87.5K as of Q3 2026.
  • Activest Wealth Management bought 14 Bristol-Myers Squibb shares in Q3 2026, an estimated $885.
  • Bristol-Myers Squibb made up 0.02% of Activest Wealth Management's portfolio in Q3 2026, its #196 holding.
  • Activest Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • Activest Wealth Management's Bristol-Myers Squibb position peaked at $131K in Q1 2026.
  • 1,000 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.